Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
How Heatmap Tracking Tools can increase website traffic using website analytics for digital publishers?
Most of the media companies are competing in content marketing in the online world and battling with the question, whether their content is faring well than the others. Analytics and metrics give…
|
Object-Oriented Programming Concepts in PHP - Part 1
Object is a type of programming language principle added to php5, that helps in building complex, reusable web applications.
|
How to create custom Form with CRUD (Create, Delete, Update) operations in Drupal 8
Custom form with CRUD operations is basically custom building a form, which can be used for storing the data entered by a user in the database
|
Valuebound's awesome weekend at Drupal Camp Mumbai 2017
Valuebound sponsors & presents sessions at Drupal Camp Mumbai 2017, with a tremendous response at the Valuebound Booth for getting hired, participants were excited
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
